{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "POLICY FOR TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES (CJD AND vCJD)"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21011"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "02 March 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "01 March 2024"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "National Institute for Health and Clinical Excellence. Patient safety and reduction of risk of transmission of Cretzfeldt- Jacob disease (CJD)"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Harm Free Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Dowling Head of Nursing Infection Prevention and Control MSE"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Infection Prevention and Control Committees Basildon Hospital Broomfield Hospital Southend Hospital"
                    },
                    {
                        "text": "05 January 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dawn Patience Director Harm Free Care"
                    },
                    {
                        "text": "05 January 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "23 February 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "March 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet \u2610 Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 3,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Jakub Cesak"
                    },
                    {
                        "text": "Decontamination Lead MSE"
                    },
                    {
                        "text": "04 December 2020"
                    },
                    {
                        "text": "Jenny Tebby"
                    },
                    {
                        "text": "Assistant Decontamination Lead MSE"
                    },
                    {
                        "text": "04 December 2020"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Committee if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "MSE Infection Control Committee"
                    },
                    {
                        "text": "23 February 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Hand Decontamination Policy Medical Equipment Management & Training Policy Linen Handling Policy Policy for the Management of Mattresses (Including the Management of Dynamic Mattress Systems) and Pillows Standard Precautions Policy for the Management of Spillage of Biological Fluids"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Dowling and Jakub Cesak"
                    },
                    {
                        "text": "Newly created MSE Document. Supersedes CP/PO/00023, IC010, 04078"
                    },
                    {
                        "text": "02 March 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ........................................................................ 6"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Diagnosis and treatment ............................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Identification of patients at risk from CJD/ vCJD ........................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Tissue infectivity ........................................................................................................... 9"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "General Care of CJD/vCJD ........................................................................................ 10"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "Table 2: Actions to take following the patient's response to \u2018Have you ever been notified that you are at risk of CJD/vCJD?' ........................................................................ 11"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Additional recommendations for surgery and neuro-endoscopy which may involve contact with high risk tissue only (Appendix2) ................................................................... 11"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Table 3: CJD risk questions for patients about to undergo elective or emergency surgical or neuro-endoscopic procedures likely to involve contact with tissues of potentially high level infectivity: ........................................................................................................... 12"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Table 4: Actions to be taken following questions in Table 3 ....................................... 12  Invasive clinical procedures (Surgery and Endoscopy) .............................................. 14  Collection of laboratory samples and other invasive medical procedures ................... 16  Training Requirements ............................................................................................... 17  Monitoring and Audit ................................................................................................... 18  Approval and Implementation ..................................................................................... 18  Equality Impact Assessment ....................................................................................... 18  References ................................................................................................................. 18 Appendix 1 - Infection Control Notification Sheet ............................................................... 20 Appendix 2 - Tissue infectivity ........................................................................................... 21"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 3 \u2013 Algorithm Summarising CJD/vCJD Risk Assessment Process for Patients Undergoing Elective or Emergency Surgical or Endoscopic Procedures ........................... 22Appendix 4 - Elective Theatre Pathway for Handling Instruments on Patients in High Risk Category for CJD/vCJD ..................................................................................................... 23"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 5: Actions to be taken with instruments following risk assessment for CJD/vCJD24 Appendix 6: Preliminary Equality Analysis ......................................................................... 25"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Transmissible Spongiform Encephalopathies (TSEs) are sometimes known as prion diseases, are rare, fatal degenerative brain diseases, which occur in humans and certain other animal species. The commonest human TSE is Creutzfeldt-Jacob Disease (CJD). This occurs in various forms:"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sporadic CJD"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Variant CJD (v CJD)"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Familial CJD"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Iatrogenic CJD"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "Classic (sporadic) CJD occurs worldwide with a frequency of approximately one per million population per annum. vCJD is thought to have resulted from oral exposure to the bovine spongiform encephalopathy (BSE) agent and is currently rare with approximately 176 cases in the UK up to December 2011. The abnormal prion proteins are present in certain tissues before patients show any symptoms and some carriers may remain asymptomatic. Consequently, there is a risk if contamination of instruments used during procedures such as surgery and endoscopy."
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "Prions are highly resistant to standard methods of disinfection and sterilisation, and therefore a special approach must be adopted in the care of patients, disposal of clinical waste, and handling of surgical instruments and other devices."
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.4,
                "text": "As non-CJD disease cases are extremely rare, this guidance will refer to CJD specifically. However, the principles and guidance will be the same for other prion diseases."
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.5,
                "text": "This policy is based on National guidance from the Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy (ACDP TSE) Risk Management Subgroup https://www.gov.uk/government/publications/guidance- from-the-acdp-tse-risk-management-subgroup-formerly-tse-working-group"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "The purpose of this policy is to prevent the transmission of CJD, vCJD and other human TSEs / prion diseases in healthcare settings by identifying patients at risk and ensuring measures required for surgical procedures and endoscopy, (including instrument quarantine), are followed."
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "type": "table",
            "sequence_num": 35,
            "data": {
                "num_rows": 11,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "CJD"
                    },
                    {
                        "text": "Creutzfeldt Jacob Disease (CJD)"
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director Infection Prevention and Control"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Infection Prevention and Control Committee"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "MSE"
                    },
                    {
                        "text": "Mid and South East Essex NHS Foundation Trust"
                    },
                    {
                        "text": "SSD"
                    },
                    {
                        "text": "Sterile Service Department"
                    },
                    {
                        "text": "Transmissible spongiform Encephalopathies (TSEs)"
                    },
                    {
                        "text": "Fatal degenerative brain diseases thought to be caused by unique proteins known as prions. Human TSE's, known as Creutzfeldt Jacob Disease (CJD) are divided into three groups:"
                    },
                    {
                        "text": "Idiopathic diseases"
                    },
                    {
                        "text": "(Arising from unknown cause or internal dysfunction): Sporadic CJD and sporadic fatal insomnia."
                    },
                    {
                        "text": "Familial diseases"
                    },
                    {
                        "text": "Familial CJD, Gerstmann-Straussler-Scheinker disease (GSS) and Fatal Familial Insomnia (FFI)"
                    },
                    {
                        "text": "Acquired diseases from human agents"
                    },
                    {
                        "text": "Iatrogenic CJD (transmitted as the result of past medical treatments), Kuru, (related to cannibalistic practices) or a bovine agent: variant CJD (v CJD)."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Infection Prevention and Control Committee (IPCC) is responsible for the review of this policy at least every two years, but more frequently if there are changes to Infection Prevention and Control Legislation or guidance."
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "Duties of Individuals within Trust"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "The Chief Executive has overall responsibility for the implementation of this policy. The  Chief  Executive  delegates  this  responsibility  to  the  Director  for  Infection Prevention and Control on each site."
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "The Director for Infection Prevention and Control (DIPC) has the responsibility to ensure there are adequate resources available to manage infection prevention and control across the MSE Trust"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Head of Decontamination has the responsibility to advice on any changes to this policy and ensuring that changes are implemented and the policy is followed."
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Employees have the responsibility to:"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Adhere to this policy and procedures"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Attend relevant training as appropriate to their individual role"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Participate in any relevant audit as part of the Infection Prevention and Control Audit Programme"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Identify to their line manager any problems or failings associated with the management of Transmissible Spongiform Encephalopathies (TSEs)"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Promptly report all incidents concerning the risks or exposure to Transmissible Spongiform Encephalopathies (TSEs) in accordance with the Trust's Incident Reporting Policy"
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Infection Prevention and Control Team (IPCT) responsibilities are to:"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Promote evidence-based infection prevention and control practices in line with Trust policies"
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Be responsible for the production of the policy and management procedures"
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liaise with the Occupational Health Department in the screening of staff, if screening is required"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "Occupational Health Department have responsibility to:"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Screen and monitor staff as clinically necessary"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appropriate management of care of staff members"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Diagnosis and treatment"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Diagnosis is usually made clinically. There are currently no widely available laboratory tests for human CJD although the diagnosis can be confirmed by examination of brain tissue after death. Brain biopsy may be used in investigating cases of suspected CJD but may not be definitive in establishing a diagnosis. Reaching a clinical diagnosis of CJD may take time as some patients may have an atypical presentation. There are no proven specific treatments available."
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "Identification and categorization of patients by risk"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients who have been identified of potentially being at risk of CJD will have an alert on the Medway / Lorenzo systems"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Infection Prevention and Control Team must be informed immediately when a known, suspected or at risk of CJD patient is admitted"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "It is important that strong effective communications between staff are rigidly adhered to in interdepartmental and hospital transfers"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All healthcare workers are reminded of the need to maintain patient confidentiality and unnecessary disclosure of patient clinical details"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "When considering measures to prevent transmission to patients and staff in the healthcare setting it is useful to make a distinction between symptomatic and asymptomatic patients. Symptomatic patients are those who fulfil the internationally accepted diagnosis criteria for definite, probable and possible CJD or vCJD. Asymptomatic patients are those with no clinical symptoms, but who are potentially at risk of developing one of these diseases i.e. having a medical or family history which places them in one of the risk groups."
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "In most routine clinical contact, no additional precautions are needed for the care of patients in the risk groups. However, when certain invasive interventions are performed, there is potential for exposure to the agents of TSEs. In these situations, it is essential that control measures are in place to prevent the iatrogenic transmission of TSEs."
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Table 2: Categorisation of patients by risk"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "type": "table",
            "sequence_num": 65,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Patient groups"
                    },
                    {
                        "text": "Symptomatic patients"
                    },
                    {
                        "text": "Patients who fulfil the diagnostic criteria for definite, probable or possible CJD or vCJD (see Annex B of Department of Health TSE Guidance for diagnostic criteria - https://www.gov.uk/government/publications/guidance-from-the-acdp-tse-risk-management-subgroup-formerly-tse-working-group Patients with neurological disease of unknown aetiology, who do not fit the criteria for possible CJD or vCJD, but where the diagnosis of CJD is being actively considered. Suspected Patients with neurological disease of unknown aetioigy, who do not fit the criteria for possible CJD or vCJD, where the diagnosis of CJD is being actively considered."
                    },
                    {
                        "text": "Asymptomatic Patients \u201cat increased risk\u201d from genetic forms of CJD"
                    },
                    {
                        "text": "Individuals who have been shown by specific genetic testing to be at significant risk of developing CJD Individuals who have a blood relative known to have a genetic mutation indicative of genetic CJD; Individuals who have or have had two or more blood relatives affected by CJD or other prion disease"
                    },
                    {
                        "text": "Asymptomatic Patients identified as \u201c at Increased risk\u201d of CJD/vCJD through iatrogenic exposures"
                    },
                    {
                        "text": "Recipients of hormone derived from human pituitary glands, e.g. growth hormone, gonadotrophin. In the UK the use of human-derived gonadotrophin was discontinued in 1973, and the use of cadaver-derived human growth hormone was banned in 1985. However, use of human-derived products may have continued in other countries after these dates Individuals who underwent intradural or spinal procedures before August 1992. These patients may have received a graft of human-derived dura mater and should be treated as being \u201cat risk\u201d unless evidence can be provided that human-derived dura mater was not used. Patients who received graft of human-derived dura mater before August 1992 are \u201cat increased risk\u201d of transmission of sporadic CJD Individuals who have had surgery using instruments that had been used on someone who went on to develop CJD/vCJD, or was \u201cat increased risk\u201d of CJD/vCJD Individuals who have received an organ or tissue from a donor infected with CJD/vCJD or \u201cat increased risk\u201d of CJD/vCJD Individuals who have been identified prior to high risk surgery as having received blood or blood components from 80 or more donors since 1980; Individuals who have received blood from someone who went on to develop vCJD. Individuals who have been treated with certain implicated UK sourced plasma products between 1980 and 2001. Note: A number of patients will have also been identified as \u2018at increased risk' by the CJD Incidents panel, for example due to having received blood from someone who later went on to develop vCJD. These patients and their GPs will normally have been notified of their status. On 1st April 2013 the CJD Incidents panel was disbanded. All CJD and related incidents are be managed by the local Health Protection Agency / Public Health England and the Infection Prevention and Control Team."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Identification of patients at risk from CJD/ vCJD"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "All cases where CJD is suspected should be reported by the responsible clinician (usually  a  neurologist)  to  the  National  CJD  Research  and  Surveillance  Unit (NCJDRSU)  in  Edinburgh and  to  the local  Health  Protection  Team  and  Public Health England so that any necessary action can be taken. Further details are available at  http://www.cjd.ed.ac.uk/"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Clinicians and ward staff caring for patients in whom the diagnosis of a CJD/ vCJD is being considered or investigated MUST contact the infection Prevention and Control Team as soon as possible. In particular, it is imperative that once the diagnosis has been suggested been clinical procedures using equipment intended for re-use on other patients are not carried out with put prior discussion with the IPCT"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "There  is  no  effective  test  to  identify  carriers  of  prion  disease.  Risk  prior surgery/endoscopy is determined by either a single question (all patients) or series of questions (for procedures involving high risk tissues) \u2013 see relevant sections in this policy"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Tissue infectivity"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "In addition to the risk categorization of the patient, the infectivity of the tissue being exposed / handled must be considered as some material is classed as higher risk than others- (Appendix 2). This classification will inform the healthcare workers that additional  requirements  if  any  are  needed  to  handle/dispose  of  or  reprocess equipment in contact with the affected patient."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "The  following  tissues  have  been  categorised  according  to  their  CJD  /v  CJD infectivity:"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "type": "table",
            "sequence_num": 73,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "CJD \u2013 Probable Infectivity of Human tissue and other Body Substances"
                    },
                    {
                        "text": "High Risk"
                    },
                    {
                        "text": "Medium Risk"
                    },
                    {
                        "text": "Low Risk"
                    },
                    {
                        "text": "It is believed that the most infective material is that obtained from the central nervous system and the eye: Brain Spinal cord tissue Posterior eye Optic Nerve"
                    },
                    {
                        "text": "Other tissue to be less infective : Olfactory epithelium Spinal ganglia Lymphoid tissue (vCJD only)"
                    },
                    {
                        "text": "Tissues with no evidence of infectivity : Blood Saliva Body secretions Excreta"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "General Care of CJD/vCJD"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "There is no evidence of a risk to staff, relatives from normal social or routine clinical contact with patients with or at risk of CJD/vCJD."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.2,
                "text": "Isolation"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Isolation of patients with CJD or vCJD is not necessary and they can be nursed in an open ward using standard infection control precautions in line with those used for all other patients."
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.3,
                "text": "Linen"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No additional handling or processing requirements are necessary."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.4,
                "text": "Clinical waste"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Clinical waste generated in the ward environment is unlikely to contain high risk material and should be disposed of into an orange clinical waste bag. The bag should be tagged with a black ward identification tag prior to being placed into the dirty utility hold for collection."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Waste generated in theatre and laboratories which contain high risk tissue should be handled as un-decontaminated tissue. The tissue should be placed into a sharps box and sealed. The container should be labelled with a \u2018Risk of Infection' label before being placed in the dirty utility hold for collection."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.5,
                "text": "Surgical procedures and endoscopy"
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients that are classed as symptomatic (possible, probable or definite) or at risk of CJD/vCJD must be identified prior to any surgical or endoscopic procedures."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "See Table 2."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.6,
                "text": "Pre- surgical assessment."
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Identifying patient who are known, suspected or at increased risk of CJD, as well as the type of surgical procedure due to be carried out is key to the correct management of surgical instruments."
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.7,
                "text": "All surgical and endoscopy patients must be risk assessed with regards to whether they are at increased risk of CJD or vCJD. This will be achieved by asking the following single question \u2013 \u2018Have you ever been notified that you are at risk of CJD/vCJD?' This question must be incorporated into pre-assessment and admission documentation as appropriate, in order that potential risk is identified as early as possible."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Table 2: Actions to take following the patient's response to \u2018Have"
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "text": "you ever been notified that you are at risk of CJD/vCJD?'"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "type": "table",
            "sequence_num": 91,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Patients response"
                    },
                    {
                        "text": "Action"
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "Surgery or endoscopy should proceed using normal infection prevention and control procedures unless the procedure is likely to lead to contact with high risk tissue."
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": "Surgery or endoscopy can proceed if it does not involve medium or high risk tissue. Please ask the patient to explain further the reason they were notified. Special infection prevention and control precautions should be taken for all surgery or endoscopy involving contact with medium or high infectivity tissues (see Appendix 2) and the local infection prevention and control team should be consulted for advice."
                    },
                    {
                        "text": "Unable to respond"
                    },
                    {
                        "text": "Surgery or endoscopy should proceed using normal infection prevention and control procedures unless the procedure is likely to lead to contact with high risk tissue."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Additional recommendations for surgery and neuro-endoscopy"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "text": "which may involve contact with high risk tissue only (Appendix2)"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "These additional recommendations are only applicable to those assessing patients in neurosurgical and ophthalmic surgical departments for intradural and posterior ophthalmic  surgical  procedures.  With  regards  to  endoscopy,  these  additional recommendations are only applicable to those assessing patients for intradural neuro-endoscopic procedures."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "As well as asking all patients whether they have been notified as being at increased risk of CJD/vCJD, clinicians assessing patients for procedures that involve contact with high risk tissues should ask supplementary questions (as outlined in Table 3) to assess further their CJD/vCJD risk. If a patient has answered \u2018yes' to the question \u2018Have  you  ever  been  notified  that  you  are  at  risk  of  CJD/vCJD?'  there  is  no additional need to ask the questions in Table 3 as the patient's risk status has been established."
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Table 3: CJD risk questions for patients about to undergo elective"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "text": "or emergency surgical or neuro-endoscopic procedures likely to involve contact with tissues of potentially high level infectivity:"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "type": "table",
            "sequence_num": 98,
            "data": {
                "num_rows": 5,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": "Question to patient"
                    },
                    {
                        "text": "Notes to clinician"
                    },
                    {
                        "text": "1"
                    },
                    {
                        "text": "Have you any history of CJD or other Prion disease in your family? If yes please specify"
                    },
                    {
                        "text": "Patients should be considered to be at risk from familial forms of CJD linked to genetic mutations if they have had: 1) Genetic testing, which has indicated that they are at significant risk of developing CJD or other prion disease 2) A blood relative known to have a genetic mutation of familial CJD 3) 2 or more blood relatives affected by CJD or other prion disease"
                    },
                    {
                        "text": "2"
                    },
                    {
                        "text": "Have you ever received growth hormone or gonadotrophin treatment? If yes, please specify whether the hormone was derived from human pituitary glands"
                    },
                    {
                        "text": "Recipients of hormone derived from human pituitary glands, e.g. growth hormone or gonadotrophin, have been identified as potentially at risk of CJD. In the UK the use of human-derived products may have continued to be used in other countries"
                    },
                    {
                        "text": "3"
                    },
                    {
                        "text": "Have you had surgery on your brain or spinal cord before August 1992?"
                    },
                    {
                        "text": "People who underwent neurosurgical procedures or operations for a tumour or cyst of the spine before August 1992 may have received a graft of dura mater, and should be treated as at risk unless evidence can be provided that dura mater was not used."
                    },
                    {
                        "text": "4"
                    },
                    {
                        "text": "Have you ever been contacted as potentially at-risk of CJD for public health purposes? If yes, please specify"
                    },
                    {
                        "text": "The CJD Incidents Panel has identified a number of individuals who are potentially at risk of CJD or vCJD for public health purposes. (See Appendix 1)"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Table 4: Actions to be taken following questions in Table 3"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "type": "table",
            "sequence_num": 100,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Patients response"
                    },
                    {
                        "text": "Action"
                    },
                    {
                        "text": "No to all questions"
                    },
                    {
                        "text": "Surgery or neuro-endoscopy can proceed using normal infection prevention and control procedures."
                    },
                    {
                        "text": "Yes to any of questions 1, 2 or 3"
                    },
                    {
                        "text": "Further investigation into the nature of the patient's CJD risk should be undertaken, and the patient's CJD risk assessed. This assessment of CJD risk should be recorded in the patient's medical notes/CRS for future reference. If the patient is found to be at increased risk of CJD or vCJD following investigation, or the risk status is unknown at the time of the procedure, special infection prevention and control precautions should be taken for the patient's procedure which may include specific requirements in relation to the post use management of surgical instrument. Inform The Infection Prevention and Control Team and the Head of Decontamination , Clinical Director Microbiologist/Virologist and the Senior Nurse for the area immediately to discuss plan for theatre/endoscopy procedure Please refer to the appropriate ACDP TSE Annex which gives guidance on the treatment of patients with or at increased risk of CJD or vCJD, If the patient is found to be at increased risk of CJD or vCJD staff should contact The Infection Prevention and Control Team. Further information can be found using the following link: http://www.nationalprionclinic.org/"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 101,
            "data": {
                "num_rows": 3,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Unable to respond"
                    },
                    {
                        "text": "In the event that a patient about to have emergency surgery or neuro-endoscopy is physically or otherwise unable to answer any questions, a family member, or someone close to the patient (in the case of a child, a person with parental responsibility), should be asked the CJD risk questions as set out in Table 3 prior to the surgery or neuro-endoscopy. If the family member, or someone close to the patient, is not able to provide a definitive answer to the CJD risk questions, the surgery or neuro-endoscopy should proceed with instruments being assessed in line with current ACDP TSE guidance to ensure that the appropriate management arrangements are put in place. Further guidance can be found in the ACDP TSE guidance: https://www.gov.uk/government/publications/guidance-from-the-acdp-tse-risk-"
                    },
                    {
                        "text": "management-subgroup-formerly-tse-working-group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.1,
                "text": "In addition to asking the questions above the following actions should be taken by the surgeon before any surgical procedure:"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "Check the patient's medical record for any referral letters for mention of a CJD status."
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.3,
                "text": "Consider whether there is a risk that the patient may be showing early signs of CJD i.e. undiagnosed neurological disease involving cognitive impairment or ataxia."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.4,
                "text": "Wherever possible the intervention should be performed in an operating theatre and should be performed at the end of the list."
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.5,
                "text": "Only the minimum number of healthcare workers required should be involved."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.6,
                "text": "For  asymptomatic  patients  at  risk  from  familial  or  iatrogenic  CJD,  the  same precautions apply."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.7,
                "text": "If a procedure is performed at the bedside, e.g. lumber puncture, care should be taken to ensure the environment may be readily cleaned should a spillage occur. The protective clothing described below should be worn by healthcare workers performing diagnostic procedures."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liquid repellent operating gown"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Disposable sterile gloves"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Full face visor"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.8,
                "text": "Tonsillectomy"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Some ENT surgeons may use laser techniques as an alternative to \u2018conventional' surgery for tonsillectomy. There is no evidence of the transmission of TSE's by the respiratory route. Any risk to surgeons from smoke plumes is thought to be very low, but there is no data on vCJD transfer via this route"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.9,
                "text": "Emergency surgery of a known, or high-risk patient"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The patient should be asked the questions above by the surgeon, if possible prior to the surgery; however, if the patient is physically unable to answer, the next of kin should be asked the CJD risk assessment questions prior to the patient's surgery. If this is also not possible, the CJD risk assessment must be answered as soon as possible after the operation by either the patient or next of kin. It is the responsibility of the surgeon to complete the CJD risk assessment."
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "12.9.1 Instruments used should be single use or if reusable instruments have been used they be must be placed in into a suitably sized sharps container and sealed. The sharps container should then be placed in the clinical waste hold area, ready for collection by the waste porters. Records must be kept of all disposed instruments. Therefore, the Instrument Check Sheet must be kept and sent to SSD"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Invasive clinical procedures (Surgery and Endoscopy)"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.1,
                "text": "Rationale"
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Invasive clinical procedures, including surgery and endoscopy, performed on patients who are categorised as a case of definite, probable or possible CJD/vCJD, or at risk of CJD/vCJD pose a particular problem. Prions are inherently resistance to commonly used disinfectants and methods of sterilisation. This means there is a possibility of transmission of prion diseases to other patients, even after apparently effective methods of decontamination or sterilisation have been used. For this reason, it will be necessary to destroy instruments after use on such a patient"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.2,
                "text": "General points"
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Think before carrying out such a procedure. Does it really need to be performed? Is there an equally acceptable alternative? Remember that in doing so instruments may have to be destroyed"
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "text": "However, the quality of care for the patient should remain the primary concern"
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The lead clinician must inform the Consultant Microbiologist before invasive clinical procedures are performed for further advice"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Equipment must be kept to a minimum on any definite, probable or possible case, and on any patient potentially \u2018at risk' of CJD/vCJD"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Procedures on such patients, and the practicalities of instrument handling, storage, cleaning and decontamination, or disposal, should be planned carefully in advance"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The laboratory should be informed before sending CSF or medium/high risk tissue samples on patients who may have a prion disease. The possibility of a diagnosis of CJD should be clearly stated in the written or electronic request"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In all cases to minimise the loss of instruments, single\u2010use disposable instrument should be used whenever possible. In endoscopy single use biopsy forceps should be used routinely in all patients."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All staff directly involved in procedures on patients in the risk groups, or in the subsequent re\u2010processing or disposal of potentially contaminated items, should be aware of the specific precautions, and adequately trained."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sufficient notice should be allowed for the necessary preparations, which should include informing SSD"
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A tracking system should be in place that will trace all reusable invasive medical devices back to all patients who have undergone a surgical procedure."
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.3,
                "text": "Precautions during invasive clinical procedures (surgery and endoscopy) on definite, probable, possible, or at-risk patients"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.1 Wherever appropriate and possible, the intervention should be performed in an operating theatre, and the procedure should be performed at the end of the list to allow normal cleaning of the theatre before the next session. If a procedure is performed on a ward it should take place in the treatment room and involve only the minimum number of staff required."
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.2 The following protective clothing should be worn:"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liquid repellent operation gown, over a plastic apron"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Gloves"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Mask"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Visor or goggles"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.3.3 This protective clothing should be treated as single\u2010use and disposed of by incineration after use."
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.4,
                "text": "Surgical instruments"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.4.1 The user, the individual's clinician, the Head of Decontamination and the IPCT are all jointly responsible for ensuring the correct instruments/endoscopic equipment are identified and the correct reprocessing processes are in place (See Appendix 3"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "text": "& 4)."
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.4.2 For any surgical procedure, the instruments that have been used on tissues designated as high or medium infectivity in a known or potential CJD patient must be considered as highly infectious."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 1,
                "text": "13.4.3 Therefore, single use disposable instruments should be used where ever possible. Following the procedure, all need to instruments disposed of by incineration. They MUST not be returned to the SSD."
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.4.4 Instruments must be placed in into a suitably sized sharps container and sealed. The sharps container should then be placed in the clinical waste hold area, ready for collection by the waste porters. Records must be kept of all disposed instruments and sent to the SSD"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "text": "13.4.5 Instruments and other medical devices that have been in contact with tissue of low infectivity can be cleaned, decontaminated and reused as normal. Some expensive items such as drills may be prevented from being contaminated by using shields, guards or covering, so that the entire item need not to be destroyed. The drill bit, or other parts in contact with high/medium risk tissue and the protective covering,"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "would then need to be incinerated. In practice it may be difficult to ensure protective covering and advice should be sought from the IPCT."
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Collection of laboratory samples and other invasive medical"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 1,
                "text": "procedures"
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "Body secretions and body fluids (including saliva, blood and CSF) are considered low risk for CJD/vCJD. It is therefore likely that the majority of samples taken and procedures performed on the ward will be low risk."
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "The collection of all samples should involve standard precautions (i.e. avoidance of sharps injuries and other forms of parenteral exposure) and the safe disposal of sharps and contaminated waste by incineration. The procedure should be carried out by competent staff who are aware of the hazards involved. Lumbar puncture should only be carried out by competent staff who are aware of the hazards involved. Disposable gloves and eye protection should be worn. All lumbar punctures on any patient (regardless of a possible diagnosis of CJD or vCJD) must always be carried out with single-use lumbar puncture kits"
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "Biopsy and CSF samples from cases of potential CJD should be marked with a \u2018Biohazard' on the sample, and the laboratory should be contacted before sending the specimen."
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "If samples are being sent to the National CJD Research Unit this should be arranged directly with them, including courier pick-up. If the sample is to be picked up from a Trust laboratory, the laboratory need to be informed that the sample is coming and when the courier is due to collect it."
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.5,
                "text": "Any inoculation injury (needlestick) should be handled according to trust Sharps Management Policy, including informing the Occupational Health department. Contact with small volumes of blood (including inoculation injury) is considered low risk, though it is known that transfusion of large volumes of blood and blood components may lead to vCJD transmission."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.6,
                "text": "Spillages"
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The prion is unusually resistant to inactivation techniques. Dilution is the most important element in cleaning up of blood, urine and faeces from cases of CJD and vCJD."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "DiffX is to be used for decontamination of surfaces. Prepare the DiffX solution inlitres of warm, NOT BOILING, water."
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The healthcare worker should wear disposable gloves, disposable apron and eye protection."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.7,
                "text": "Sharps injury"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Any accident involving sharps, or contamination of abrasions with blood or body fluid, should be gently encouraged to bleed, gently washed (avoid scrubbing) with warm soapy water, rinsed, dried and covered with a waterproof dressing. All needle stick injuries should be reported to the person in charge of the clinical area and a Datix form completed."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.8,
                "text": "Childbirth"
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In the event that a symptomatic or at-risk patient becomes pregnant, childbirth should be managed using standard infection control precautions. The placenta, other associated material and fluids are regarded as low risk and can be handled as per Trust Policy. Instruments used should be single use or if reusable instruments have been used they be must be placed in into a suitably sized sharps container and sealed. The sharps container should then be placed in the clinical waste hold area, ready for collection by the waste porters. Records must be kept of all disposed instruments and sent to the SSD. The Instrument Check Sheet should be kept and sent to SSD"
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.9,
                "text": "Transplant and tissue donation"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Definite, possible and probable patients should not donate blood and none of their tissue should be used for transplant purposes"
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ophthalmic transplant teams must not remove corneas from demented patients, from patients who die in psychiatric facilities and from patients with obscure undiagnosed neurological disease"
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.1,
                "text": "The ward setting"
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Following the death of a confirmed or suspected patient CJD or vCJD the removal of the body from the ward to the mortuary should be carried out using standard infection control procedures. The mortuary will supply a specialised body bag. The Department of Health state that an \u2018Infection Control Notification Sheet' should be completed and sent to the mortuary with the patient. (Appendix 1)"
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.11,
                "text": "The mortuary"
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Post-mortem examinations are required in order to confirm a clinical diagnosis and the cause of death in patients with suspected CJD or vCJD. However, such procedures have the potential to expose pathologists and mortuary staff to tissues containing high levels of infectivity. Therefore, deceased patients will be transferred to a regional neuropathology centre. The National CJD Surveillance Unit will advise mortuary staff on the nearest centre."
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "All Trust staff members are required to undertake Mandatory Infection Prevention and Control up dates. The IPCT has primary responsibility for providing training on the policy where needed. Managers have the responsibly to support the IPCT by ensuring that staff are able to attend training sessions in response to identified needs."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.1,
                "text": "Outlined  below  is  the  Trust's  process  of  monitoring  compliance  with,  and  the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "type": "table",
            "sequence_num": 173,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Duties relating to repair and maintenance"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "MEMS"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "Medical Equipment Management Group"
                    },
                    {
                        "text": "Medical Equipment Management Group"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "All  policies,  procedures  and  guidelines  will  be  approved  by  the  Site  Infection Control Committees, which are the specialist groups with the authority to approve local Policies.  These  will  then  be  forwarded  to  the  Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "It is the author's responsibility to inform the Director of Harm Free Care of  the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 6)"
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Advisory Committee on Dangerous Pathogens Transmissible Spongiform Encephalopathy Risk Management Subgroup. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. 2003. (Web site: Individual sections updated regularly. https://www.gov.uk/government/publications/guidance-from-the-acdp-tse-risk- management-subgroup-formerly-tse-working-group"
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Creutzfeldt - Jakob disease Surveillance Unit, Neuropathology Laboratory, Western General Hospital, Crewe Road, Edinburgh EH4 2XU. Telephone 0131 332 2117; fax 0131 343 1404. (http://www.cjd.ed.ac.uk)"
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Institute for Health and Clinical Excellence. Patient safety and reduction of risk of transmission of Creutzfeldt-Jacob disease (CJD) via interventional procedures. November 2006. http://www.nice.org.uk/"
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reducing the risk of transmission of Creutzfeldt\u2013Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues. January 2020. https://www.nice.org.uk/guidance/IPG666/chapter/1-Recommendations"
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reducing the risk of exposure of patients to the agent of CJD through brain biopsy procedures. Letter from the Chief Medical Officer. May 2004. http://www.dh.gov.uk"
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health Technical Memorandum (HTM) 01-01 on the management and decontamination of surgical instruments (medical devices) used in acute care. Updated 2016. https://www.gov.uk/government/publications/management-and- decontamination-of-surgical-instruments-used-in-acute-care"
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health Technical Memorandum (HTM) 01-06 provides information on the management and decontamination of flexible endoscopes. Updated 2016. https://www.gov.uk/government/publications/management-and-decontamination-of- flexible-endoscopes"
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1 - Infection Control Notification Sheet"
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 1,
                "text": "INFECTION CONTROL NOTIFICATION SHEET"
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "type": "image",
            "sequence_num": 190,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 191,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Name of deceased:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Date of death:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Time of death:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Source hospital:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Source ward:"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 192,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "The deceased remains are a potential source of infection (See note below \u2013 ring as appropriate) If yes (see note 2 below)"
                    },
                    {
                        "text": "Yes \u2610"
                    },
                    {
                        "text": "Unknown \u2610"
                    },
                    {
                        "text": "The remains present an infectious hazard of transmission by (note 2): (tick as appropriate)"
                    },
                    {
                        "text": "Inoculation \u2610"
                    },
                    {
                        "text": "Aerosol \u2610"
                    },
                    {
                        "text": "Ingestion \u2610"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Instructions for handling remains (if yes above, tick as appropriate)"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "type": "image",
            "sequence_num": 194,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Body bagging  \u2610 Embalming presents high risk  \u2610"
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "type": "table",
            "sequence_num": 196,
            "data": {
                "num_rows": 3,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Signed: (note 3)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Print name:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "On behalf of:"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Hospital \u2610 Mortuary \u2610 General \u2610 Practitioner"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 197,
            "data": {
                "num_rows": 4,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Notes"
                    },
                    {
                        "text": "Note 1"
                    },
                    {
                        "text": "Not all patients display typical symptoms; therefore some infections may not have been identified at the time of death."
                    },
                    {
                        "text": "Note 2"
                    },
                    {
                        "text": "In accordance with Health and safety Law and the information provided in the Health Services Advisory Committee Guidance: Safe Working and the Prevention of Infection in the Mortuary and Post Mortem Room (Second Edition 2002)."
                    },
                    {
                        "text": "Note 3"
                    },
                    {
                        "text": "In hospital cases, the doctor identifying death, in consultation with ward nursing staff, is asked to sign this notification sheet. Where a post-mortem examination has been undertaken, the pathologist is asked to sign this notification sheet. In hospital situations, the general practitioner certifying death is asked to sign this notification sheet."
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2 - Tissue infectivity"
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "type": "table",
            "sequence_num": 199,
            "data": {
                "num_rows": 24,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Tissue"
                    },
                    {
                        "text": "CJD - Assumed level of Infectivity"
                    },
                    {
                        "text": "vCJD - Assumed level of Infectivity"
                    },
                    {
                        "text": "Brain"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "Spinal cord"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "Cranial nerved (entire optic nerve and intracranial portions of others)"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "Cranial ganglia"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "Posterior eye"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "High"
                    },
                    {
                        "text": "Olfactory epithelium"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Spinal ganglia"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Tonsil"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Gut associated lymph node tissue"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Appendix"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Spleen and thymus"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Other lymph node tissue"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Medium"
                    },
                    {
                        "text": "Dura mater (reclassified December 2010)"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Anterior eye and cornea"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Peripheral nerve"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Skeletal muscle"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Dental pulp"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Gingival tissue"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Blood and bone marrow"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "CSF"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Placenta"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Urine"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Other tissue"
                    },
                    {
                        "text": "Low"
                    },
                    {
                        "text": "Low"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for transmissible spongiform encephalopathies"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(CJD AND vCJD)/ MSEPO-21011/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 31.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3 \u2013 Algorithm Summarising CJD/vCJD  Risk Assessment Process for Patients Undergoing Elective or Emergency Surgical or Endoscopic Procedures"
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "type": "image",
            "sequence_num": 204,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.001.png"
            }
        },
        {
            "type": "image",
            "sequence_num": 205,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.004.jpeg"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 31.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for transmissible spongiform encephalopathies"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(CJD AND vCJD)/ MSEPO-21011/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 4 - Elective Theatre Pathway for Handling Instruments on Patients in High Risk Category for CJD/vCJD"
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Theatre / Endoscopy Microbiologist"
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "type": "image",
            "sequence_num": 211,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.005.png"
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "PRE OP \u2013 table 3  Patient identified  / Sterile Services Manager / Infection Prevention &"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Control Team & the Theatre Manager"
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Planning Procedure  Post Procedure  Post Procedure  Storage Inform Sterile Services  Minimise traffic  \uf0b7  Reusable medical  \uf0b7  Clean all surfaces  Theatre Manager /"
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "type": "image",
            "sequence_num": 215,
            "data": {
                "url": "MSEPO-21011 MSE Transmissible spongiform encephalopathies (CJD vCJD) 1.0.010.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Manager / Theatre  devised to be  with Tristel  Sterile Services"
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Manager / Infection Manager  Tphroet ecfoltliovwe icnlgo thing  amccanoardagednc ie n with  \uf0b7  Prevention Control to"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Put patient last on  should be worn:  mUse ops/csinglole thusse  be contacted to list  ACDP TSE guidance  arrange management"
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Liquid-repellent  of instruments until"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Minimise use of  operation gown,  \uf0b7  Dispose of single  \uf0b7  Clean all other  diagnosis has been reusable medical  over a plastic  use instruments via  surfaces as per  confirmed"
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "text": "standard policy"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 0,
                "text": "devices  apron  dedicated Sharps"
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "bin/container"
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Ward \u2013 patient does"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Decide on disposal  \uf0b7  Gloves  \uf0b7  Mark specimens as  not require isolation"
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "text": "of reusable"
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 0,
                "text": "instruments based  \uf0b7  Mask  high risk and send"
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "text": "to laboratory"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "text": "upon procedure/"
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "text": "patient  \uf0b7  Visor or goggles"
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Put all remaining"
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "text": "categorisation of"
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 0,
                "text": "waste in clinical"
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 0,
                "text": "patients by risk"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "text": "waste bag for"
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 0,
                "text": "table 1"
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 0,
                "text": "incineration"
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 31.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for transmissible spongiform encephalopathies"
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(CJD AND vCJD)/ MSEPO-21011/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 5: Actions to be taken with instruments following risk assessment for CJD/vCJD"
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Actions to be taken with instruments following risk assessment for CJD/vCJD:"
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a) Definite or probable CJD/TSE diagnosis"
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "text": "b) Possible CJD/TSE diagnosis"
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "type": "table",
            "sequence_num": 245,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "PATIENT CATEGORY"
                    },
                    {
                        "text": "TISSUE"
                    },
                    {
                        "text": "ACTION"
                    },
                    {
                        "text": "1a, 2 and 3"
                    },
                    {
                        "text": "High or medium risk"
                    },
                    {
                        "text": "Incinerate instruments after use"
                    },
                    {
                        "text": "1a, 2 and 3"
                    },
                    {
                        "text": "Low risk(confirmed)"
                    },
                    {
                        "text": "Reprocess"
                    },
                    {
                        "text": "1b"
                    },
                    {
                        "text": "High or medium risk"
                    },
                    {
                        "text": "Test patient for prion disease. Quarantine instruments until test result received; incinerate if prion disease present or denote for single patient use; reprocess if prion disease not present"
                    },
                    {
                        "text": "1b"
                    },
                    {
                        "text": "Low risk(confirmed)"
                    },
                    {
                        "text": "Reprocess"
                    },
                    {
                        "text": "4"
                    },
                    {
                        "text": "High, medium or low risk"
                    },
                    {
                        "text": "Reprocess"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 246
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Policy for transmissible spongiform encephalopathies"
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(CJD AND vCJD)/ MSEPO-21011/ 1.0"
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 6: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Transmissible spongiform encephalopathies (CJD vCJD): (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "type": "table",
            "sequence_num": 251,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 252,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Aline site existing policies"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "One MSE Policy"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "All staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 253,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Head Nurse Infection Control MSE"
                    },
                    {
                        "text": "28 February 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 25.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 255
        }
    ]
}